Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1999 May; 80(3-4): 569–578.
Published online 1999 May 1. doi:  10.1038/sj.bjc.6690393
PMCID: PMC2362349

Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours


M2A antigen is an oncofetal antigen associated with germ cell neoplasia, present in testis on fetal gonocytes and re-expressed on carcinoma in situ (CIS) and germ cell tumours. We developed a panel of monoclonal antibodies (mAb), M2A (IgG2a), D1-26 (IgG2b) and D2-40 (IgG1), to this antigen in order to characterize its structure and study its distribution among germ cell tumours. M2A antigen was purified by sequential lectin and antibody affinity chromatography and characterized as a monomeric Mr 40 000 surface sialoglycoprotein, extensively glycosylated with O-linked carbohydrate structures, but devoid of N-linked sugars. Terminal sialic acid residues were required for reactivity with mAb M2A and D1-26, but not D2-40. Sections of 69 testicular germ cell tumours, fixed in formalin and embedded in paraffin, were stained with mAb D2-40 to examine the distribution of M2A antigen. Uniform membrane staining was observed in seminomas, and focal staining in 69% of embryonal carcinomas, 29% of teratomas and 25% of yolk sac tumours. CIS in the vicinity of all germ cell tumours also displayed uniform membrane staining. The characterization of M2A antigen, and the development of mAb which react with it in conventionally preserved archival specimens, provide important initiatives to study the origin and progression of germ cell neoplasia. © 1999 Cancer Research Campaign

Keywords: germ cell neoplasia, monoclonal antibodies, oncofetal antigen

Full Text

The Full Text of this article is available as a PDF (197K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A. Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5291–5295. [PubMed]
  • Bailey D, Baumal R, Marks A. Use of anti-seminoma monoclonal antibody to confirm the diagnosis of mediastinal seminoma. A case report. APMIS. 1988 Mar;96(3):206–210. [PubMed]
  • Bailey D, Marks A, Stratis M, Baumal R. Immunohistochemical staining of germ cell tumors and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphatase and a monoclonal anti-seminoma antibody. Mod Pathol. 1991 Mar;4(2):167–171. [PubMed]
  • Baumal R, Bailey D, Giwercman A, Skakkebaek N, Stratis M, Marks A. A novel maturation marker for human Sertoli cells. Int J Androl. 1989 Oct;12(5):354–359. [PubMed]
  • Buckman R, De Angelis C, Shaw P, Covens A, Osborne R, Kerr I, Reed R, Michaels H, Woo M, Reilly R, et al. Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3. Gynecol Oncol. 1992 Oct;47(1):102–109. [PubMed]
  • Carraway KL, Hull SR. O-glycosylation pathway for mucin-type glycoproteins. Bioessays. 1989 Apr;10(4):117–121. [PubMed]
  • Giwercman A, Marks A, Bailey D, Baumal R, Skakkebaek NE. A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. APMIS. 1988 Aug;96(8):667–670. [PubMed]
  • Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS. 1991 Jul;99(7):586–594. [PubMed]
  • Giwercman A, Andrews PW, Jørgensen N, Müller J, Graem N, Skakkebaek NE. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis. Cancer. 1993 Aug 15;72(4):1308–1314. [PubMed]
  • Goss PE, Schwertfeger L, Blackstein ME, Iscoe NA, Ginsberg RJ, Simpson WJ, Jones DP, Shepherd FA. Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer. 1994 Apr 1;73(7):1971–1979. [PubMed]
  • Jacobsen GK, Nørgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):323–329. [PubMed]
  • Jørgensen N, Rajpert-De Meyts E, Graem N, Müller J, Giwercman A, Skakkebaek NE. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest. 1995 Feb;72(2):223–231. [PubMed]
  • King BL, Peng HQ, Goss P, Huan S, Bronson D, Kacinski BM, Hogg D. Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families. Cancer Res. 1997 Jan 15;57(2):209–214. [PubMed]
  • Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol. 1994 Dec;17(3):153–180. [PubMed]
  • Meng FJ, Zhou Y, Skakkebaek NE, Marks A, Giwercman A. Detection and enrichment of carcinoma-in-situ cells in semen by an immunomagnetic method using monoclonal antibody M2A. Int J Androl. 1996 Dec;19(6):365–370. [PubMed]
  • Nicholson PW, Harland SJ. Inheritance and testicular cancer. Br J Cancer. 1995 Feb;71(2):421–426. [PMC free article] [PubMed]
  • Peters BP, Ebisu S, Goldstein IJ, Flashner M. Interaction of wheat germ agglutinin with sialic acid. Biochemistry. 1979 Nov 27;18(24):5505–5511. [PubMed]
  • Plummer TH, Jr, Elder JH, Alexander S, Phelan AW, Tarentino AL. Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. J Biol Chem. 1984 Sep 10;259(17):10700–10704. [PubMed]
  • Rajpert-De Meyts E, Skakkebaek NE. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl. 1994 Apr;17(2):85–92. [PubMed]
  • Rajpert-De Meyts E, Kvist M, Skakkebaek NE. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch. 1996 Jun;428(3):133–139. [PubMed]
  • Schneider C, Newman RA, Sutherland DR, Asser U, Greaves MF. A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem. 1982 Sep 25;257(18):10766–10769. [PubMed]
  • Sheldon K, Marks A, Baumal R. Characterization of binding of four monoclonal antibodies to the human ovarian adenocarcinoma cell line HEY. Biochem Cell Biol. 1987 May;65(5):423–428. [PubMed]
  • Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987 Feb;10(1):19–28. [PubMed]
  • Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res. 1991 Apr 1;51(7):1811–1816. [PubMed]
  • Sutherland DR, Rudd CE, Greaves MF. Isolation and characterization of a human T lymphocyte-associated glycoprotein (gp40). J Immunol. 1984 Jul;133(1):327–333. [PubMed]
  • Sutherland DR, Watt SM, Dowden G, Karhi K, Baker MA, Greaves MF, Smart JE. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. Leukemia. 1988 Dec;2(12):793–803. [PubMed]
  • Tarentino AL, Maley F. Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus. J Biol Chem. 1974 Feb 10;249(3):811–817. [PubMed]
  • von der Maase H, Rørth M, Walbom-Jørgensen S, Sørensen BL, Christophersen IS, Hald T, Jacobsen GK, Berthelsen JG, Skakkebaek NE. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986 Nov 29;293(6559):1398–1401. [PMC free article] [PubMed]
  • von der Maase H, Giwercman A, Müller J, Skakkebaek NE. Management of carcinoma-in-situ of the testis. Int J Androl. 1987 Feb;10(1):209–220. [PubMed]
  • Wu AM, Sugii SJ, Herp A. A guide for carbohydrate specificities of lectins. Adv Exp Med Biol. 1988;228:819–847. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK